Use of step therapy protocols for the treatment of neurological conditions prohibited.

This bill prohibits health insurance plans in Minnesota from using step therapy protocols to limit coverage for FDA-approved drugs used to treat neurological conditions. It directly affects people with neurological disorders and the health plans that provide their coverage. Under this law, insurers cannot require patients to try other medications first if the prescribed drug is FDA-approved and aligns with clinical practice guidelines. The restrictions apply to plans offered, issued, or renewed on or after January 1, 2027.